Document is current
Any future updates will be listed below
-
Authors
Schock, Lisa https://orcid.org/0009-0009-0615-5752
Friedel, Anna Lena
Siegel, Sonja
Unger, Nicole
van Baal, Lukas
Honegger, Jürgen
Giese, Sabrina
Deutschbein, Timo
Detomas, Mario
Wrede, Karsten
Ahmadipour, Yahya
Kreitschmann-Andermahr, Ilonka
-
Funding
Funding for this research was provided by:
Universitätsklinikum Essen
- License Information
-
More Information
Article History
Received: 4 September 2025
Accepted: 18 January 2026
First Online: 9 March 2026
Declarations
:
: SoS received research support and/or travel grants and/or consultation fees from Recordati Rare Diseases GmbH Germany, IPSEN Pharma GmbH Germany, Advanz Pharma GmbH, Pfizer Pharma GmbH Germany and Pfizer Co. MD has received financial support from Ipsen to travel and attend a scientific congress; he has also served on an advisory board for Recordati. IKA has received travel grants, speakers fees and/or consulting fees from the following manufacturers of acromegaly medications: Recordati Rare Diseases, Advanz Pharma, IPSEN, Pfizer and Camurus. LS, ALF, NU, LvB, JH, SG, TD, KW and YA declare to have no competing interests in relation to the content of this article.
